Prevalence and genetic diversity of pneumococcal serogroup 6 in Australia

Clinical Microbiology and Infection

Volumn 17, Issue 8, 2011, Pages 1246-1253

  Zhuo, F ^a,b,d   Xiao, M ^c   Kong, F ^b   Oftadeh, S ^b   Zhou, F ^b   Zhang, J ^a   Gilbert, G L ^b  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b Western Sydney Area Health Service   (Australia)

^c PEKING UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Antibiotic susceptibility; Diversity; Genotypes; Serotypes 6C and 6D; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; AUSTRALIA; BACTERIUM ISOLATION; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMOCOCCAL SEROTYPE 6C; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEROTYPE; SEROTYPING; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS PNEUMONIAE;

EID: 79960671350     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03404.x     Document Type: Article

References (31)

1. Kadioglu A, Weiser JN, Paton JC et al. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 2008; 6: 288-301.
2. Sorensen UB. Typing of pneumococci by using 12 pooled antisera. J Clin Microbiol 1993; 31: 2097-2100.
3. Park IH, Park S, Hollingshead SK et al. Genetic basis for the new pneumococcal serotype, 6C. Infect Immun 2007; 75: 4482-4489.
4. Park IH, Pritchard DG, Cartee R et al. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol 2007; 45: 1225-1233.
5. Carvalho Mda G, Pimenta FC, Gertz RE Jr. et al. PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007. J Clin Microbiol 2009; 47: 554-559.
6. Nahm MH, Lin J, Finkelstein JA et al. Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine. J Infect Dis 2009; 199: 320-325.
7. Nunes S, Valente C, Sá-Leão R et al. Temporal trends and molecular epidemiology of recently described serotype 6C of Streptococcus pneumoniae. J Clin Microbiol 2009; 47: 472-474.
8. Hermans PW, Blommaart M, Park IH et al. Low prevalence of recently discovered pneumococcal serotype 6C isolates among healthy Dutch children in the pre-vaccination era. Vaccine 2008; 26: 449-450.
9. Bratcher PE, Park IH, Hollingshead SK et al. Production of a unique pneumococcal capsule serotype belonging to serogroup 6. Microbiology 2009; 155: 576-583.
10. Jin P, Kong F, Xiao M et al. First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children. J Infect Dis 2009; 200: 1375-1380.
11. Bratcher PE, Kim KH, Kang JH et al. Identification of natural pneumococcal isolates expressing serotype 6D by genetic, biochemical and serological characterization. Microbiology 2010; 156: 555-560.
12. Jin P, Xiao M, Kong F et al. Simple, accurate, serotype-specific PCR assay to differentiate Streptococcus pneumoniae serotypes 6A, 6B, and 6C. J Clin Microbiol 2009; 47: 2470-2474.
13. Enright MC, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 1998; 144: 3049-3060.
14. Moore MR, Gertaz RE Jr, Woodbury RL et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States. J Infect Dis 2008; 197: 1016-1027.
15. Kong F, Gilbert GL. Using cpsA-cpsB sequence polymorphisms and serotype-/group-specific PCR to predict 51 Streptococcus pneumoniae capsular serotypes. J Med Microbiol 2003; 52: 1047-1058.
16. CLSI. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement, Vol. 28, No. 1. Approved standard M2-A9. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
17. Mavroidi A, Godoy D, Aanensen DM, Robinson DA, Hollingshead SK, Spratt BG. Evolutionary genetics of the capsular locus of serogroup 6 pneumococci. J Bacteriol 2004; 186: 8181-8192.
18. Lexau CA, Lynfield R, Danila R et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005; 294: 2043-2051.
19. O'Brien KL, Moulton LH, Reid R et al. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. Lancet 2003; 362: 355-361.
20. Roche PW, Krause V, Cook H et al. Invasive pneumococcal disease in Australia. Commun Dis Intell 2008; 32: 18-30.
21. Whitney CG, Farley MM, Hadler J et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348: 1737-1746.
22. Whitney CG, Pilishvili T, Farley MM et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006; 368: 1495-1502.
23. Byington CL, Samore MH, Stoddard GJ et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 2005; 41: 21-29.
24. Hicks LA, Harrison LH, Flannery B et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007; 196: 1346-1354.
25. Singleton RJ, Hennessy TW, Bulkow LR et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007; 297: 1784-1792.
26. Campos LC, Carvalho Mda G, Beall BW et al. Prevalence of Streptococcus pneumoniae serotype 6C among invasive and carriage isolates in metropolitan Salvador, Brazil, from 1996 to 2007. Diagn Microbiol Infect Dis 2009; 65: 112-115.
27. Jacobs MR, Bajaksouzian S, Bonomo RA et al. Occurrence, distribution, and origins of Streptococcus pneumoniae serotype 6C, a recently recognized serotype. J Clin Microbiol 2009; 47: 64-72.
28. Jacobs MR, Good CE, Bajaksouzian S et al. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin Infect Dis 2008; 47: 1388-1395.
29. Park IH, Moore MR, Treanor JJ et al. Differential effects of pneumococcal vaccines against serotypes 6A and 6C. J Infect Dis 2008; 198: 1818-1822.
30. Mahon BE, Hsu K, Karumuri S et al. Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens. Vaccine 2006; 24: 2514-2520.
31. Guttman DS, Dykhuizen DE. Clonal divergence in Escherichia coli as a result of recombination, not mutation. Science 1994; 266: 1380-1383.